Brief: XORTX Therapeutics Provides Update On FDA Type B Meeting Request
30/04/2025 12:12
April 30 (Reuters) - XORTX Therapeutics Inc XRTX.V: XORTX PROVIDES UPDATE ON FDA TYPE B MEETING REQUEST XORTX THERAPEUTICS INC - EXPECTS TO FILE GOUT NDA IN H1 2026 Source text: ID:nGNX2D2C7m Further company coverage: XRTX.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM